mRNA (messenger RNA) is a genetic material which carries the genetic information from DNA to ribosome and where it specifies the sequence of amino acids for the protein synthesis. mRNA vaccines and therapeutics are prepared with the help of advanced technology and offers the most efficient and cost effective options with reduced side effects with increased immunogenicity. The demand for mRNA vaccines & therapeutics has increased due to the increase in various diseases such as cancer, infectious disease such as ebola virus, zika virus and many more.
mRNA Vaccines and Therapeutics Market is valued at USD 587.7 million in 2018 and expected to reach USD 2.91 Billion By 2026 with the CAGR of 28.51% over the forecast period.
Get Sample of this Premium Report@ https://brandessenceresearch.com/requestSample/PostId/566
Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that function as a basis for protein synthesis within the cells.
And an mRNA (messenger RNA) vaccine is a novel type of vaccine for providing acquired immunity through an RNA containing vector, such as lipid nanoparticles. mRNA vaccines and Therapeutics integrates the desirable immunological properties and are produced in laboratories using mammalian cells. Upon the introduction of the vaccine into the body, this mRNA sequence is translated by the host cells to produce the encoded antigens, which then arouse the body’s adaptive immune system to produce antibodies against the pathogen. RNA vaccines provide multiple advantages compared to DNA vaccines in terms of production, administration, and safety and have been shown to be promising in clinical trials involving humans, which have increased the demand of mRNA vaccine & therapeutic market.
The growing occurrences of chronic and infectious diseases, such as diabetes, HIV, cancer and CVDs, is one of the major key factors driving the growth of the market. The growing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections as well as inability of traditional vaccine approach to find vaccines at the critical time are also providing a boost to the market growth. Compared to conventional medicines, mRNA vaccines and Therapeutics are developed with the help of advanced technologies which are more effective against pathogens, have higher effectiveness, improved immunogenicity and are require less cost to produce. Moreover, developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market growth.
Global mRNA Vaccines Market: Market Player Analysis
Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, Etherna, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc., Pfizer
mRNA Vaccines and Therapeutics Market report is segmented on type, mechanism of action, application and by regional & country level. Based upon type, mRNA vaccines and therapeutics market is segmented into Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, and mRNA Therapeutic for Other Diseases. On the basis of mechanism of action, the market is segmented into Bioengineered Vaccine, Gene Therapy (Gene Silencing/Suppression), Gene Transcription (Protein Generation), Cell Therapy, Monoclonal Antibody, and Others. Based upon application, mRNA vaccines and therapeutics market is classified into Infectious Disease, Cancer, and Other.
Global mRNA Vaccines & Therapeutics Market: By Type
- Standardization of Cancer Treatment mRNA Vaccine
- Individualized Cancer Treatment mRNA Vaccine
- Infectious Disease Treatment mRNA Vaccine
- Infection Prevention mRNA Vaccine
Global mRNA Vaccines & Therapeutics Market: By End Users
- Infectious Disease
On the basis of end user, global mRNA Vaccines & Therapeutics market is segmented into infectious diseases, cancer and others. Infectious diseases segment is dominating in the mRNA vaccine & therapeutic market with market worth of USD 204.7 million in 2019 and is estimated to reach USD 1015.5 million in 2026 with market share of 28.53%, due to ongoing research & development activity by various manufacturers.
The regions covered in global mRNA vaccines & therapeutics market are North America, Europe, Asia-Pacific and Rest of the World. Based on country level, global mRNA Vaccines & Therapeutics market sub divided into U.S., Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Brazil, Mexico, GCC, Africa, etc. North America is dominating the mRNA vaccine & therapeutic market, due to presence of major players, growing research & development on this topic and present Covid-19 pandemic situation. The North American market was worth of USD 218.6 million in 2019, expected to reach USD 1098.7 million in 2026 with CAGR of 28.78% in forecasting period.
Messenger Ribonucleic Acid (mRNA) refers to a single-stranded molecule of RNA in the genome that acts as a basis for protein synthesis within the cells. The rising prevalence of chronic diseases such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the global mRNA vaccines & therapeutics market. According to World Health Organization (WHO), an estimated 17.9 million people died from CVDs in 2016, among these deaths, 85% are due to heart attack and stroke. According to the American Heart Association, Coronary heart condition is that the leading cause (45.1 percent) of deaths due to disorder within the US for the year 2017.
Coronary heart disease accounts for 1 in 7 deaths in the US and over 360,000 people died annually. According to Centers for Disease Control and Prevention (CDC), coronary heart disease is the most common type of heart disease, died 365,914 peoples in 2017. According to WHO, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke by 2030. According to the European Heart Network AISBL, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Moreover, increasing licensing agreements between mRNA vaccine manufacturers, prominent vaccine developers’ to offer advanced infectious disease vaccination and growing adoption of mRNA vaccine due to its higher efficiency and shorter manufacturing times are some of the drivers expected to accelerate the global mRNA vaccines & therapeutics market growth in forecast period.
Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/566
Another major driving factor for the growth of mRNA vaccines & therapeutics market due to the growing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections. Report by NCBI, WHO estimates that about one billion people are infected and up to 500,000 people die from influenza each year in the world.
Increase in licensing agreements with increased prevalence of chronic disorders is the key factor which helps mRNA Vaccines and Therapeutics Market to grow.
Over the period of time there has been tremendous increase in the prevalence of cronic disorders and infectious diseases on a large scale. Furthermore, constant increase in the various infections disease has increased the demand for effective and efficient vaccines and therapeutics for the treatment. There has been significant increase in the licensing agreement between manufacturers for the development of mRNA vaccine and therapeutics. Moreover, increase in approval of from various regulatory bodies such as FDA, CE and others are also expected to drive the growth of mRNA vaccines and therapeutic market. Increased adoption of mRNA vaccines and therapeutics and reduced manufacturing time has also promoted the market growth. The increase in research and development activities coupled with advanced technology is expected to create ample opportunities on a long run. However, high cost involved in the development of mRNA vaccine and therapeutic market is expected to hinder the growth of mRNA vaccines and therapeutics market in the near future.
Key Benefits of Global Mrna Vaccine Market Report
- Global Mrna Vaccine Market report covers in-depth historical and forecast analysis.
- Global Mrna Vaccine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global Mrna Vaccine Market report helps to identify opportunities in marketplace.
- Global Mrna Vaccine Market report covers extensive analysis of emerging trends and competitive landscape.
Table of Content
- Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
- Chapter – Global Mrna Vaccine Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Mrna Vaccine Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Mrna Vaccine Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
- Chapter – Global Mrna Vaccine Market Overview: Quantitative Analysis
- Chapter – Global Mrna Vaccine Market Analysis: Segmentation By Type
- Chapter – Global Mrna Vaccine Market Analysis: Segmentation By Application
Get Detailed Analysis: https://brandessenceresearch.com/healthcare/mrna-vaccines-and-therapeutics-market
Brandessence Market Research & Consulting Pvt ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.